Fig. 1From: ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signalingSchematic illustration of synthesis and the mechanism of the therapeutic effect of DTP@DMF NPsBack to article page